ROMA™ (for postmenopausal patients)

Evidencio uses JavaScript for many of its features. Please enable JavaScript to enable calculations

The ROMA™ is developed to support clinical decision making by informing clinical management on the estimated risk of ovarian malignancy in premenopausal or postmenopausal women who present with an ovarian adnexal mass.

Research authors: Richard G. Moore, D. Scott McMeekin, Amy K. Brown, Paul DiSilvestro, M. Craig Miller, W. Jeffrey Allard, Walter Gajewski, Robert Kurman, Robert C. Bast Jr., Steven J. Skates

Version: 1.32

Public
Gynaecology
{{ modelType }}

V-1.32-9927.26.03.17

(01)08720938015168(8012)v1.32(4326)260317(240)9927

Download the User manual and consult the Intended purpose.

Algorithm
Details
Intended purpose
Electronic label
Release Notes
User manual
{{ toolbarErrorMessage }}

Units

Calculate the result

This algorithm does not calculate automatically.
Please provide all the needed parameters and press calculate.

Set more parameters to perform the calculation

Risk of ovarian malignancy

Set more parameters to perform the calculation

Risk of ovarian malignancy %

Result interval {{ additionalResult.min }} to {{ additionalResult.max }}

Conditional information

Your text input(s) have been changed. Please update your result. Update

This model can be used to estimate the risk of ovarian malignancy in postmenopausal patients.

PRO

Note

Notes are only visible in the result download and will not be saved by Evidencio

Calculations alone should never dictate patient care, and are no substitute for professional judgement. See our full disclaimer.

Underlying algorithms Part of

Additional information

Details

Algorithm author

Evidencio

Algorithm ID

9927

Version

1.32.{{ model.microversion }}

Revision date

2026-03-17

Specialty

Gynaecology , Oncology

Algorithm type

Custom calculation ^{(Calculation)}

MeSH terms

Surgical Oncology

Ovarian Cancer

Gynecology

Status

Public

Formula

Study characteristics

Additional information

A total of 566 patients were enrolled from 12 different geographic sites across the United States. Of the 566 patients enrolled onto the trial, 531 patients were evaluable, with 283 postmenopausal women and 248 premenopausal women. A total of 54 women had menopausal status determined by plasma FSH levels, 47 of which had a prior hysterectomy with preservation of at least one ovary. The mean age of the evaluable study cohort was 54 years old (range: 18 to 87), with a mean age for postmenopausal women of 65 years old (range: 42 to 87) and for premenopausal 41 years old (range: 18 to 59). There were 352 women with benign disease (150 postmenopausal and 202 premenopausal) and 179 women with a malignancy diagnosed in the study group.

Study Population

Total population size: 531

Additional characteristics

No additional characteristics defined

Supporting Publications

Title or description

Related files

No related files available

Extra Information

	Evidencio B.V., Irenesingel 19, 7481 GJ Haaksbergen, The Netherlands
	V-1.32-9927.26.03.17
	(01)08720938015168(8012)v1.32(4326)260317(240)9927
	Download the User manual
	Medical device In vitro diagnostic medical device

Download the Declaration of conformity

This algorithm has been certified as a medical device

V-1.32-9927.26.03.17

Medical Devices

Evidencio offers CE-certified MDSWs (Medical Device Software) of both widely adopted and new ground breaking algorithms. Evidencio provides an easy, sustainable and scalable way to be compliant in your use of algorithms and AI for clinical decision support, shared decision making, patient monitoring, etc.

The algorithm ROMA™ (for postmenopausal patients) has been certified as a medical device and is only available to qualified Evidencio subscribers.

In general, the prediction models and algorithms that are freely available on Evidencio are intended for research and education purposes only.

Some of the medical prediction models and algorithms that are available on Evidencio are classified as (e.g. CE) Medical Devices.
This implies that these algorithms may be used for clinical decision making by medical professionals, as long as this use strictly adheres to the algorithm’s Intended Purpose statements.

{{ collapsed.intendedUse ? $t('show_intended_use') : $t('hide_intended_use') }}

In order for Evidencio to comply with legislation regarding the use of medical devices, we must monitor use of these medical devices to the greatest extent to prevent mis-use. Therefore, the Medical Devices on Evidencio can only be used by named Evidencio Subscribers.

To access this algorithm you will need an Evidencio Pro Subscription

Visit our library for more prediction algorithms

Already have an account? Log in Go back Sign Up

This is a paid algorithm

The algorithm ROMA™ (for postmenopausal patients) is only available for users that are subscribed to it.

Visit our library for more prediction algorithms

Evidencio Pro

€9,99 / Month

This functionality is reserved for Pro subscribers.
Please support us by registering as Evidencio Pro.

Clinical & Commercial use licence

Create licenced algorithms

Unlimited Patient specific reports

Create direct access for peer reviewers.

Use licensed algorithms

Cancel at any time

For a complete list of all the benefits, see Services

Looking to manage Teams Or EHR integration? Get in touch with our team.

Signup for Pro subscription

Select the version you want to duplicate Are you sure you want to duplicate this algorithm?

Please sign in to enable Evidencio print features

In order to use the Evidencio print features, you need to be logged in.
If you don't have an Evidencio Community Account you can create your free personal account at:

https://www.evidencio.com/registration

Printed results - Examples {{ new Date().toLocaleString() }}

Evidencio Community Account Benefits

With an Evidencio Community account you can:

Create and publish your own prediction algorithms.
Share your prediction algorithms with your colleagues, research group, organization or the world.
Review and provide feedback on algorithms that have been shared with you.
Validate your algorithms and validate algorithms from other users.
Find algorithms based on Title, Keyword, Author, Institute, or MeSH classification.
Use and save prediction algorithms and their data.
Use patient specific protocols and guidelines based on sequential algorithms and decision trees.
Stay up-to-date with new algorithms in your field as they are published.
Create your own lists of favorite algorithms and topics.

A personal Evidencio account is free, with no strings attached!
Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction algorithms.

Disclaimer: Calculations alone should never dictate patient care, and are no substitute for professional judgement.

Browse

Create

Browse

Create

Login

Sign Up

{{ section.title }}

Calculate the result

Risk of ovarian malignancy %

Conditional information

Details

Study characteristics

Additional information

Study Population

Additional characteristics

Supporting Publications

Related files

This algorithm has been certified as a medical device

This is a paid algorithm

Select the version you want to duplicate Are you sure you want to duplicate this algorithm?

Non-medical device

Please sign in to enable Evidencio print features

Printed results - Examples {{ new Date().toLocaleString() }}

Evidencio Community Account Benefits

{{ variable.title }}

Result display